Understanding how a specific gene affects immune responses in asthma during viral infections

Molecular understanding of the GSDMB-regulated innate immune response

NIH-funded research University of Virginia · NIH-11250342

This study is looking at how a specific gene might affect how children's immune systems respond to respiratory viruses, which can make asthma worse, and it hopes to find ways to help kids with asthma who are more likely to have serious reactions to these infections.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Virginia NIH-funded
Lab location1 site (Charlottesville, United States)
Project IDNIH-11250342 on NIH RePORTER

What this research studies

This research investigates the role of the Gasdermin B (GSDMB) gene in the immune response to respiratory viruses, particularly focusing on how these infections can trigger asthma exacerbations in children. By examining the innate immune response activated by viral infections, the study aims to uncover the mechanisms that lead to increased susceptibility to asthma in genetically predisposed individuals. The research utilizes advanced molecular techniques to analyze how viral RNA is recognized by the immune system and how this recognition influences the severity of asthma symptoms. The findings could provide insights into personalized treatment strategies for children with asthma who are at risk of severe reactions to respiratory viruses.

Who could benefit from this research

Good fit: Ideal candidates for this research are children aged 0-11 years who have a history of asthma and respiratory viral infections.

Not a fit: Patients who do not have asthma or are older than 11 years may not receive benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved treatments and preventive strategies for children with asthma, particularly those affected by viral infections.

How similar studies have performed: Previous research has shown promising results in understanding the genetic factors influencing asthma exacerbations, suggesting that this approach could yield valuable insights.

Where this research is happening

Charlottesville, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.